Medication info
Sitagliptin 100 mg (Sitagliptin Hydrochloride Monohydrate)

Sitagliptin 100 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
Film-coated tablets that are round, biconvex, and light brown in color
Packaging
PTP - 28 tablets/box [(14 tablets/PTP×2)]
Approval status
Active

MFDS item code 202101321 · Approved 2021.02.16 · Insurance code 656005360

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at a dose of 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function is recommended before starting treatment with this medicine and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for type 2 diabetes patients
View approved original text

This medication is used alongside diet and exercise to help manage blood sugar control in patients with type 2 diabetes. Initially, it is used alone, but if blood sugar control is inadequate, it can be combined with metformin. Additionally, it can be added to other medications for blood sugar control, such as sulfonylureas, metformin, thiazolidinediones, and insulin, when their monotherapy or combination therapy is insufficient. This medication helps provide effective blood sugar management when used with various treatment methods. It improves blood sugar control in type 2 diabetes.

How to take

Adult dose

This medicine is administered at a dose of 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function is recommended before starting treatment with this medicine and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication can rarely cause severe allergic reactions, so if symptoms such as skin rash or difficulty breathing occur, use should be discontinued immediately and medical consultation should be sought. Additionally, serious adverse reactions such as pancreatitis, which is inflammation of the pancreas, have been reported; if symptoms such as abdominal pain, vomiting, or nausea occur, medical personnel should be notified immediately. Patients with type 1 diabetes or those who are hypersensitive to this medication should not use it, and those with impaired kidney function should take caution and adjust the dosage accordingly. When using this medication, hypoglycemic symptoms may occur, so especially when taken with insulin or sulfonylureas, blood sugar levels should be monitored frequently, and attention should be paid to hypoglycemic symptoms. Mild adverse reactions such as headache, upper respiratory tract infection, and nasopharyngitis may occur during treatment, and if severe joint pain or blistering skin symptoms develop, notify a doctor immediately. Women who are pregnant or breastfeeding are advised to avoid using this medication, and the safety in children and adolescents under 18 years old has not been established. Elderly patients may have impaired kidney function, so periodic kidney function tests should be performed before and after taking this medication, and if an overdose occurs, immediate visit to a medical facility for appropriate treatment is required. When used in combination with other drugs, potential interaction should be considered, so consultation with a doctor or pharmacist before use is mandatory.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • rhinitis
  • headache
  • diarrhea
  • abdominal pain
Show 33 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • rash
  • urticaria
  • cutaneous vasculitis
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • elevated low-density lipoprotein
  • hyperglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air from entering. It is best to store at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Film-coated tablets that are round, biconvex, and light brown in color

Package unit

PTP - 28 tablets/box [(14 tablets/PTP×2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.